Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBR SystemsEBRCZ +5.34%22 3-Year EBITDA Growth Rate is 4.10% as of Mar. 2026, which is 81% below its 10-year median of 22.15. GuruFocus rates EBRCZ with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 693 Medical Devices & Instruments companies, EBR Systems ranks worse than 58.15% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of EBR Systems was 40.20% per year. The lowest was 4.10% per year. And the median was 22.15% per year.
EBR Systems (OTCPK:EBRCZ) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
EBR Systems 3-Year EBITDA Growth Rate Related Terms
EBRCZ vs OWLT, APYX, INGN: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, EBR Systems's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBR Systems 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EBR Systems's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where EBR Systems's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.10% mean?
EBR Systems (EBRCZ) has a 3-Year EBITDA Growth Rate of 4.10% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EBR Systems and its competitors. This is 81% below median its historical median of 22.15. Over the past decade, EBR Systems' 3-Year EBITDA Growth Rate has ranged from 4.10 to 40.20. According to the industry distribution chart, EBR Systems ranks #403 out of 693 companies in the Medical Devices & Instruments industry, placing it in the top 58.2%.
Is EBR Systems' 3-Year EBITDA Growth Rate too high?
EBR Systems' current 3-Year EBITDA Growth Rate of 4.10% is 81% below median its 10-year median of 22.15. Over the past 10 years, this metric has ranged from a low of 4.10 to a high of 40.20. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.10. EBR Systems' value of 4.10% is 49.4% below this industry median. Based on the distribution chart, EBR Systems ranks #403 out of 693 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, EBR Systems has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does EBR Systems' 3-Year EBITDA Growth Rate compare to OWLT and APYX?
According to the Medical Devices & Instruments industry distribution chart, EBR Systems ranks #403 out of 693 companies for 3-Year EBITDA Growth Rate. This places EBR Systems in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.10. EBR Systems' value of 4.10% is 49.4% below this benchmark. Historically, EBR Systems' own 3-Year EBITDA Growth Rate has ranged from 4.10 to 40.20 over the past decade. While the company's 10-year median is 22.15 vs. the industry median of 8.10, EBR Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.10, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBR Systems's current 3-Year EBITDA Growth Rate of 4.10% is 49.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EBR Systems and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBR Systems's current 3-Year EBITDA Growth Rate is 4.10%, which is 81% below median its own 10-year median of 22.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBR Systems stock overvalued right now?
EBR Systems (EBRCZ) has a current 3-Year EBITDA Growth Rate of 4.10%. The current 3-Year EBITDA Growth Rate is 4.10%, which is 81% below median its 10-year median of 22.15 and 49.4% below the Medical Devices & Instruments industry median of 8.10. EBR Systems' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For EBR Systems (EBRCZ), the current 3-Year EBITDA Growth Rate is 4.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside the left ventricle of the heart. It conducts its operations in the United States.
22GF Score
Get the complete analysis for EBRCZ
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBRCZ has been successfully added to your 
